http://scienceblogs.com/insolence/2010/11/23/luc-montagnier-the-nobel-disease-strikes, November 23, 2010.
Gorski, D. «The Nobel Disease Meets DNA Teleportation and Homeopathy,» http://scienceblogs.com/?s=the+nobel+prize+meets+dna+teleportation, January 14, 2011.
Gorski, D. «Luc Montagnier and the Nobel Disease,» June 4, 2012, http://www.sciencebasedmedicine.org/luc-montagnier-and-the-nobel-disease.
Montagnier, L. «Autism: The Microbial Track,» www.autismone.org/content/keynote-microbial-track.
Salzberg, S. «Nobel Laureate Joins Anti-Vaccination Crowd at Autism One,» Forbes, May 27, 2012.
Ullman, D. «Luc Montagnier, Nobel Prize Winner, Takes Homeopathy Seriously,» Huffington Post, January 30, 2011.
Вакцина MMR и аутизм
Chen, R.T., and F. DeStefano. «Vaccine Adverse Events: Causal or Coincidental?» Lancet 351 (1998): 611–612.
Dales, L., S. J. Hammer, and N. J. Smith, «Time Trends in Autism and in MMR Immunization Coverage in California,» Journal of the American Medical Association 285 (2001): 1183–1185.
Davis, R. L., P. Kramarz, K. Bohlke, et al. «Measles-Mumps-Rubella and Other Measles-Containing Vaccines Do Not Increase the Risk for Inflammatory Bowel Disease: a Case-Control Study from the Vaccine Safety Datalink Project,» Archives of Pediatric Adolescent Medicine 155 (2001): 354–359.
DeStefano, F., and W. W. Thompson. «MMR Vaccine and Autism: an Update of the Scientific Evidence,» Expert Review of Vaccines 3 (2004): 19–22.
DeStefano, F., T. K. Bhasin, W. W. Thompson, et al. «Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects: a Population-Based Study in Metropolitan Atlanta,» Pediatrics 113 (2004): 259–266.
Farrington, C. P., E. Miller, and B. Taylor. «MMR and Autism: Further Evidence Against a Causal Association,» Vaccine 19 (2001): 3632–3635.
Fombonne, E., and S. Chakrabarti. «No Evidence for a New Variant of Measles-Mumps-Rubella-Induced Autism,» Pediatrics 108 (2001): E58.
Honda, H., Y. Shimizu, and M. Rutter, «No Effect of MMR Withdrawal on the Incidence of Autism: a Total Population Study,» Journal of Child Psychology and Psychiatry 4 (2005): 572–579.
Kaye, J. A., M. Mar Melero-Montes, and H. Jick, «Mumps, Measles, and Rubella Vaccine and the Incidence of Autism Recorded by General Practitioners: a Time Trend Analysis,» British Medical Journal 322 (2001): 460–463.
Madsen, K. M., and M. Vestergaard. «MMR Vaccination and Autism: What Is the Evidence for a Causal Association?» Drug Safety 27 (2004): 831–840.
Miller, E. «Measles-Mumps-Rubella Vaccine and the Development of Autism,» Seminars in Pediatric Infectious Diseases 14 (2003): 199–206.
Public Health Laboratory Service. «Measles Outbreak in London,» Communicable Diseases Report Weekly 12 (2002): 1.
Stratton, K., A. Gable, and P. M. M. Shetty. «Measles-Mumps-Rubella Vaccine and Autism,» Institute of Medicine, Immunization Safety Review Committee. Washington, D.C.: National Academies Press, 2001.
Taylor, B., E. Miller, C. P. Farrington, et al. «Autism and Measles, Mumps, and Rubella Vaccine: No Epidemiological Evidence for a Causal Association,» Lancet 353 (1999): 2026–2029.
Taylor, B., E. Miller, R. Lingam, et al. «Measles, Mumps, and Rubella Vaccination and Bowel Problems or Developmental Regression in Children with Autism: a Population Study,» British Medical Journal 324 (2002): 393–396.
Wakefield, A. J., S. H. Murch, A. Anthony, et al. «Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children,» Lancet 351 (1998): 637–641 (retracted).
Weiss, S. «Eat Dirt — The Hygiene Hypothesis and Allergic Diseases,» New England Journal of Medicine 347 (2002): 390–391.
Wilson K., E. Mills, C. Ross, et al. «Association of Autistic Spectrum Disorder and the Measles, Mumps, and Rubella Vaccine: a Systematic Review of Current Epidemiological Evidence,» Archives of Pediatric and Adolescent Medicine 157 (2003): 628–634.
Тиомерсал
Andrews, N., E. Miller, A. Grant, et al. «Thimerosal Exposure in Infants and Developmental Disorders: a Retrospective Cohort Study in the United Kingdom Does Not Show a Causal Association,» Pediatrics 114 (2004): 584–591.
Centers for Disease Control and Prevention. «Thimerosal in Vaccines: a Joint Statement of the American Academy of Pediatrics and the Public Health Service,» Morbidity and Mortality Weekly Report 48 (1999): 563–565.
Centers for Disease Control and Prevention. «Recommendations Regarding the Use of Vaccines that Contain Thimerosal as a Preservative,» Morbidity and Mortality Weekly Report 48 (1999): 996–998.
Clark, S. J., M. D. Cabana, T. Malik, et al. «Hepatitis B Vaccination Practices in Hospital Newborn Nurseries Before and After Changes in Vaccination Recommendations,» Archives of Pediatric Adolescent Medicine 155 (2001): 915–920.
Fombonne, E., R. Zakarian, A. Bennett, et al. «Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links with Immunization,» Pediatrics 118 (2006): 139–150.
Gundacker, C., B. Pietschnig, K. J. Wittmann, et al. «Lead and Mercury in Breast Milk,» Pediatrics 110 (2002): 873–878.
Heron, J., J. Golding, and the ALSPAC Study Team. «Thimerosal Exposure in Infants and Developmental Disorders: a Prospective Cohort Study in the United Kingdom Does Not Show a Causal Association,» Pediatrics 114 (2004): 577–583.
Hviid, A., M. Stellfeld, J. Wohlfahrt, et al. «Association Between Thimerosal-Containing Vaccine and Autism,» Journal of the American Medical Association 290 (2003): 1763–1766.
Institute of Medicine (US) Immunization Safety Review Committee, D. Stratton, A. Gable, and M. C. McCormick (eds.). Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, D.C.: National Academies Press, 2001.
Marsh, D. O., T. W. Clarkson, C. Cox, et al. «Fetal Methylmercury Poisoning: Relationship Between Concentration in Single Strands of Maternal Hair and Child Effects,» Archives of Neurology 44 (1987): 1017–1022.
Nelson, K. B., and M. L. Bauman. «Thimerosal and Autism?» Pediatrics 111 (2003): 664–679.
Parker, S. K., B. Schwartz, J. Todd, et al. «Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: a Critical Review of Published Original Data,» Pediatrics 114 (2004): 793–804.
Thompson, W. W., C. Price, B. Goodson, et al. «Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years,» New England Journal of Medicine 357 (2007): 1281–1292.
Verstraeten, T., R. L. Davis, F. DeStefano, et al. «Safety of Thimerosal-Containing Vaccines: a Two-Phased Study of Computerized Health Maintenance Organization Databases,» Pediatrics 112 (2003): 1039–1048.
Электронные сигареты
American Academy of Pediatrics. «Electronic Nicotine Delivery Systems,» Pediatrics 136 (2015): 1018–1026.
Brown, J., E. Beard, D. Kotz, et al. «Real-World Effectiveness of E-Cigarettes When Used to Aid Smoking Cessation: A Cross-Sectional Population Study,» Addiction 109 (2014): 1531–1540.
Clarke, T. «Youth E-Cigarette Data Prompts Call to Speed Regulation,» Reuters, April 18, 2015.
Davidson, L. «Vaping Takes Off as E-Cigarettes Break Through $6BN,» Telegraph, June 23, 2015.
Farsalinos, K. E., and R. Poisa. «Safety Evaluation and Risk Assessment of Electronic Cigarettes as Tobacco Cigarette Substitutes: A Systematic Review,» Therapeutic Advances in Drug Safety 5 (2014): 67–86.
Friedman, A. S. «How Does Electronic Cigarette Access Affect Adolescent Smoking?» Journal of Health Economics, October 19, 2015, doi:10.1016/j.healeco.2015.10.003.
Green, S. H., R. Bayer, and A. L. Fairchild. «Evidence, Policy, and E-Cigarettes — Will England Reframe the Debate,» New England Journal of Medicine 374 (2016): 1301–1303.
Haelle, T. «Teen Vaping Triples: E-Cigarettes, Hookahs Threaten Drop in Teen Tobacco Use,» Forbes, April 17, 2015.
Haelle, T. «E-Cigarettes Benefit Public Health If Used to Replace Smoking, Say British Doctors,» Forbes, April 28, 2016.
Herzog, B. «Will Electronic Cigarettes Pass Combustible Cigarette Sales Within the Next 10 Years,» www.breatheic.com/blog/will-electronic-cigarette-pass-combustible-cigarette-sales-within-the-next-10-years-2/.
Jamal, A., I. T. Israel, E. O’Connor, et al. «Current Cigarette Smoking Among Adults — United States, 2005–2013,» Morbidity and Mortality Weekly Report 63 (2014): 1108–1112.
Jamal, A. J., D. M. Homa, E. O’Connor, et al. «Current Cigarette Smoking Among Adults — United States, 2005–2014,» Morbidity and Mortality Weekly Report 64 (2015): 1235–1240.
Klein, J. D. «Electronic Cigarettes Are Another Route to Nicotine Addiction for Youth,» Journal of the American Medical Association Pediatrics, September 8, 2015, doi:10.1001/jamapediatrics.2015.1929.
McNeill, A. B., C. R. Hitchman, P. Hajek, and H. McRobbie. E-Cigarettes: An Evidence Update, A Report Commissioned by Public Health England. Public Health England, August 2015.
Nitzkin, J. «E-Cigarettes: A Life Saving Technology or a Way for Tobacco Companies to Re-Normalize Smoking in American Society,» The Food and Drug Law Institute 4 (2014): 1–17.
Nitzkin, J. «Understanding the Crusade Against E-Cigarettes,» rstreet.org, November 23, 2015.
Nocera, J. «Is Vaping Worse Than Smoking?» New York Times, January 27, 2015.
Satel, S. «What’s Driving the War on E-Cigarettes?»